AMRX Amneal Pharmaceuticals Inc Class A

Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company manufacture and commercialize complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products. The company has class B common shares outstanding that are privately held.

$3.36  +0.18 (5.66%)
As of 07/01/2022 16:00:02 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  05/13/2013
Outstanding shares:  150,807,252
Average volume:  656,419
Market cap:   $479,567,061
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BFNF1D6
Valuation   (See tab for details)
PE ratio:   287.60
PB ratio:   1.30
PS ratio:   0.23
Return on equity:   2.89%
Net income %:   0.54%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy